The Journal of Intellectual Property Law and Practice (JIPLP) has published an article by Darren Smyth on a significant series of cases, which included drug manufacturer Warner-Lambert obtaining a court order requiring NHS England to issue guidelines to doctors when prescribing the generic pregabalin for the treatment of neuropathic pain to patients, to prescribe by reference to the brand name Lyrica® and not the generic name pregabalin. The judge also explained the meaning of Swiss-form claims for the first time.
To read the article in full, click here.